Nanomol Technologies has begun its participation in the project Nano-Nafres (COMRDI15-1-0023)

Nanomol Technologies has begun its participation in the project Nano-Nafres (COMRDI15-1-0023) that belongs to the RIS3CAT community “Technologies applied to health”.

The objective of this project is to perform preclinical and clinical studies on the application of nanoformulated epithelial growth factor in venous ulcers.

This project has been cofounded 50% by the European Regional Development Funds from the European Union within the framework of the operative FEDER program in Catalonia 2014-2020.